Newstral
Article
bizjournals.com on 2018-04-23 14:15
Sage Therapeutics asks FDA to approve lead drug for postpartum depression
Related news
- Eyeing FDA approval, Sage lays out strategy for dual postpartum depression drugsbizjournals.com
- FDA Approves Sage Therapeutics’ Zulressowsj.com
- FDA approves first postpartum depression drugKVUE News
- FDA approves first postpartum depression pillpressherald.com
- FDA approves first oral postpartum depression pillengadget
- FDA Approves First Pill for Postpartum DepressionThe New York Times
- FDA committee recommends Sage's postpartum depression drugbizjournals.com
- GPostpartum Depression Drug Approved by FDA With a Major ProblemGuardian Liberty Voice
- FDA approves first pill to treat postpartum depressionstaradvertiser.com
- NFDA approves 1st drug for treating postpartum depressionnypost.com
- FDA approves first drug specifically for postpartum depressionWashington Post
- Sage Therapeutics surges on postpartum depression drug studyseattletimes.com